Search engine for other government resources

Risedronate MedlinePlus Drug Information

Risedronate tablets and delayed-release (long-acting tablets) are used to prevent and treat osteoporosis (a condition in which the bones become thin ...
medlineplus.gov/druginfo/meds/a601247.html

Risedronate a new oral bisphosphonate

Risedronate, the newest oral bisphosphonate, is approved by the US Food and Drug Administration for the prevention and treatment of postmenopausal ...
pubmed.ncbi.nlm.nih.gov/11589256/

Risedronate sodium C7H10NNaO7P2 - PubChem

Create. 2005-09-13. Risedronate Sodium is the sodium salt of risedronic acid, a synthetic pyridinyl bisphosphonate. Risedronic acid binds to ...
pubchem.ncbi.nlm.nih.gov/compound/Risedronate-sodium

Efficacy and safety of risedronate 150-mg once a month in ...

Introduction: Risedronate is effective in the treatment of postmenopausal osteoporosis in oral daily, weekly, or on two consecutive days per month ...
pubmed.ncbi.nlm.nih.gov/22752050/

Efficacy of risedronate on clinical vertebral fractures ...

Risedronate has been shown to reduce the incidence of radiographically-defined vertebral fractures by approximately two-thirds within 1 year. Research ...
pubmed.ncbi.nlm.nih.gov/15119979/

A comparison of the effect of alendronate and risedronate ...

Objectives: To compare alendronate 70 mg once weekly (OW) with risedronate 35 mg OW with respect to change in bone mineral density (BMD), biochemical ...
pubmed.ncbi.nlm.nih.gov/18324951/

Risedronate sodium monohydrate C7H12NNaO8P2 - PubChem

Risedronate sodium monohydrate. Risedronate sodium hydrate. UNII-F67L43UT5C. F67L43UT5C. 353228-19-0
pubchem.ncbi.nlm.nih.gov/compound/Risedronate-sodium-monohydrate

Risedronic acid C7H11NO7P2 - PubChem

Risedronate binds to bone hydroxyapatite and, at the cellular level, inhibits osteoclasts. Although the osteoclasts adhere normally to the bone ...
pubchem.ncbi.nlm.nih.gov/compound/Risedronic-acid

Effects of Risedronate on Osteoarthritis of the Knee - PubMed

The purpose of the present study was to discuss the effects of risedronate on osteoarthritis (OA) of the knee by reviewing the existing literature ...
pubmed.ncbi.nlm.nih.gov/20191005/

Comparison of the effects of three oral bisphosphonate ...

Greater effects were observed for ibandronate (and alendronate) than risedronate at the spine but not the hip. Introduction: Generally, comparative ...
pubmed.ncbi.nlm.nih.gov/25074351/

Cost-effectiveness of gastro-resistant risedronate tablets ...

The use of gastro-resistant risedronate, a convenient dosing regimen for oral bisphosphonate therapy, seems a cost-effective strategy compared with ...
pubmed.ncbi.nlm.nih.gov/30701342/

WITHDRAWN Risedronate for the prevention and treatment of ...

Risedronate, a third generation bisphosphonate, has been shown in multiple clinical trials to reduce fracture risk and improve bone mineral density in ...
pubmed.ncbi.nlm.nih.gov/17636764/

PDF HIGHLIGHTS OF PRESCRIBING INFORMATION ...

FULL PRESCRIBING INFORMATION . 1 INDICATIONS AND USAGE 1.1 Postmenopausal Osteoporosis . ACTONEL is indicated for the treatment and prevention of ...
www.accessdata.fda.gov/drugsatfda_docs/label/2009/020835s035lbl.pdf

PDF Actonel risedronate sodium Tablet Film Coated DESCRIPTION

name of risedronate sodium is [1-hydroxy-2-(3-pyridinyl)ethylidene]bis[phosphonic acid] monosodium salt. The chemical structure of risedronate sodium ...
www.accessdata.fda.gov/drugsatfda_docs/label/2007/020835s028lbl.pdf

PDF OFFICE OF CLINICAL PHARMACOLOGY REVIEW

Risedronate sodium is a pyridinyl bisphosphonate drug with the empirical formula for the hemipentahydrate as C7H10NO7P2Na 2.5 H2O [MW 350.13]. The ...
www.accessdata.fda.gov/drugsatfda_docs/pediatric/020835s035_Risedronate_Clinpharm_BPCA.pdf

DailyMed - RISEDRONATE SODIUM tablet film coated

Risedronate is not indicated for use in pediatric patients. The safety and effectiveness of risedronate was assessed in a one-year, randomized ...
dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a42a35e6-3e08-4b4f-ae56-47d4aec2322a

History of risedronate - PubMed

Risedronate was shown to significantly reduce serum alkaline phosphatase and clinical features in patients with Paget's disease and was approved for ...
pubmed.ncbi.nlm.nih.gov/32387834/

DrugsFDA FDA-Approved Drugs

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS; ACTONEL: RISEDRONATE SODIUM: 30MG: TABLET;ORAL: Prescription ...
www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020835

DailyMed - RISEDRONATE SODIUM tablet delayed release

Risedronate is a pyridinyl bisphosphonate that inhibits osteoclast-mediated bone resorption and modulates bone metabolism. Each risedronate sodium ...
dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=95fce48f-5ebc-4d49-a97c-1e4f2a71d507

PDF ACTONEL with CALCIUM DESCRIPTION ACTONEL with CALCIUM is ...

The chemical name of risedronate sodium is [1-hydroxy-2-(3 pyridinyl)ethylidene]bis[phosphonic acid] monosodium salt. The chemical structure of rised ...
www.accessdata.fda.gov/drugsatfda_docs/label/2015/021823s011lbl.pdf